e-learning
resources
Munich 2006
Monday 04.09.2006
Pulmonary hypertension: diagnostic tools and therapeutic approaches
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Acetylene single breath estimation of effective pulmonary blood flow in patients with pulmonary arterial hypertension (PAH)
L. S. Mackay, T. Small, A. J. Fisher, J. Lordan, P. A. Corris (Newcastle upon Tyne, United Kingdom)
Source:
Annual Congress 2006 - Pulmonary hypertension: diagnostic tools and therapeutic approaches
Session:
Pulmonary hypertension: diagnostic tools and therapeutic approaches
Session type:
Thematic Poster Session
Number:
2480
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. S. Mackay, T. Small, A. J. Fisher, J. Lordan, P. A. Corris (Newcastle upon Tyne, United Kingdom). Acetylene single breath estimation of effective pulmonary blood flow in patients with pulmonary arterial hypertension (PAH). Eur Respir J 2006; 28: Suppl. 50, 2480
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Intra-breath CO-diffusion and pulmonary blood flow at rest and during exercise in pulmonary arterial hypertension and pulmonary fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 403s
Year: 2004
Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2007; 29: 944-950
Year: 2007
Effect of riociguat on pulmonary arterial compliance in patients with pulmonary arterial hypertension (PAH) in the RESPITE study
Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials
Year: 2017
Exhaled breath olfactory signature of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020
6MWD in patients with pulmonary arterial hypertension (PAH)
Source: Eur Respir J 2003; 22: Suppl. 45, 464s
Year: 2003
Arterial blood gases during exercise in chronic obstructive pulmonary disease with and without pulmonary hypertension
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Single arterial occlusion to locate resistance in patients with pulmonary hypertension
Source: Eur Respir J 2003; 21: 31-36
Year: 2003
Towards an understanding of pulmonary arterial hypertension (PAH): gene regulation patterns in pulmonary arterial resistance vessels of patients with PAH
Source: Eur Respir J 2006; 28: Suppl. 50, 526s
Year: 2006
Usefulness of differential blood gas exchange assessment in patients with severe pulmonary arterial hypertension (PAH) associated to congenital heart disease (CHD)
Source: Eur Respir J 2005; 26: Suppl. 49, 351s
Year: 2005
Multiple dimensional analysis of arterial blood gas and pulmonary function in patients with COPD
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012
Comparison of arterial and venous blood gases analysis in patients with exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 326s
Year: 2007
Pulmonary arterial pressure predicts nocturnal hypoxemia in CTEPH patients.
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018
The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease
Source: Eur Respir J 2013; 41: 217-223
Year: 2013
Elevated pulmonary capillary pressure in pulmonary arterial hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 3s
Year: 2001
Mobile spiroergometry for prediction of survival in pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
Lower than expected pulsatile pulmonary arterial load in a thromboembolic pulmonary hypertension model
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018
Pulmonary functions and arterial blood gases in portal hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 522s
Year: 2001
Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021
Pulmonary distension restrains pulmonary blood flow during exercise in COPD patients
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008
The influence of fractional pulse pressure on the outcome of pulmonary thromboendarterectomy
Source: Eur Respir J 2001; 17: 653-659
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept